platform / run

The running trial, and the data behind it, in one view.

Vivo is the control tower for your active trial: what’s happening, what changed since you last looked, what needs your attention, and the recommended action — always in view, always traceable to source.

Trial Home

Know what changed before the meeting starts.

Trial Home gives study teams a continuously updated view of what is happening across the trial, what changed since the last review, what needs attention, and what actions are pending. Designed for the rhythm of real clinical development work.

Current status across enrollment, sites, vendors, data quality, safety, and protocol

What changed since the last review cycle

Emerging risks that require attention

Open alerts, issues, assignments, and review items

Trial News summaries for cross-functional teams

Trial Home

Trial status: On track. 3 items need attention.

Site 104: Enrollment 40% behind plan — 18 days no screenings

Safety signal: AE cluster at Site 104 (Cohort B) — review recommended

Central lab feed: data refresh overdue by 3 days

12 other items unchanged since last review

Last updated: 4 hours ago · Next refresh in 2h

Study Operations & Safety Oversight

Oversee active trials and the data behind them.

Every oversight view drills through to the underlying records — subject, visit, site, and source — so review never ends at a chart.

Enrollment tracking & forecasting

Actual vs. planned screening and enrollment, with trial- and site-level forecasts — slippage visible while there is still time to act on it.

Participant profiles & timelines

The full subject picture — history, events, visits, and measures on one longitudinal timeline.

Safety oversight & DSMB prep

AE and SAE review in clinical context, with evidence packages assembled for DSMB and safety committees.

Every measure, inspectable

Labs, questionnaires, assessments, and ECG intervals over time — plus imaging reads with read operations, turnaround, and e-signature status where imaging vendors are connected.

Comparative site performance

Enrollment, deviations, data quality, and visit compliance ranked across sites — best practices surfaced, laggards flagged.

Insights, alerts & actions

Scheduled analyses run on your cadence. Findings arrive as alerts, and alerts become tracked actions with owners and history.

Every one of these views is a workspace: filter it, plot it, save it, export it — the same pattern on every dataset in the trial, from adverse events to imaging reads.

In vivo

The running trial, birds eye view.

Individual subject profile in Vivo: longitudinal timeline of dosing, safety events, and measures with an event details panel

One participant, the whole story — dosing, safety, and measures on a single timeline. Demonstration trial, synthetic data.

Vivo safety overview: adverse event KPIs with incidence and causality rankings

Safety oversight at a glance — the evidence a DSMB prep starts from. Demonstration trial, synthetic data.

Trial Site Oversight

Site startup, conduct, and closeout — tracked end to end.

Vivo tracks each site’s lifecycle via TMF integration: activation progress, document readiness, conduct signals, and closeout status — connected to the same operating picture as enrollment, safety, and data quality.

Startup: activation milestones and document completeness by site

Conduct: visit compliance, deviations, and data quality per site

Closeout: outstanding queries, reconciliation, and archive readiness

Site Lifecycle

Site 112 · Activated

Docs 100%

Site 118 · In startup

2 docs pending · 12 days to target

Site 097 · Closeout

4 open queries

TMF integrated · document status straight from the source systems

“Our CMO went from spending a week plus manually collating and creating the various tables he wanted for DSMB to maybe 30, 45 minutes. That’s just transformative to how we do business.”

VP, Clinical Operations · Alzheimer’s Disease Global Phase 2 Trial

Stop assembling status. Start acting on it.

Live with sponsors today. Most teams are running active trial oversight in 6–8 weeks.